Structure | Chemical Name | CAS | MF |
|
1-TRITYLIMIDAZOLE-2-CARBOXALDEHYDE
|
67478-50-6
|
C23H18N2O
|
|
4-(2-Pyrimidinyl)-1-piperazinyl(3,4,5-trimethoxyphenyl) ketone
|
67479-04-3
|
C18H22N4O4
|
|
Crayvallac SF
|
67479-81-6
|
|
|
Zonyl
|
67479-85-0
|
|
|
ZONYL(R) FSP
|
67479-86-1
|
(RfCH2CH2O)xPO(ONH4)3-x
|
|
Calamine
|
67479-94-1
|
HO8Si2Zn-7
|
|
methylcholanthrene-9,10-dihydrodiol
|
67481-32-7
|
C21H18O2
|
|
4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzoicacid
|
67482-10-4
|
C12H8N4O2
|
|
3-CHLOROTHIOPHENE-2-CARBALDEHYDE
|
67482-48-8
|
C5H3ClOS
|
|
4,5-Dichlorothiophene-2-carbaldehyde
|
67482-49-9
|
C5H2Cl2OS
|
|
Cysteine, N-(aminocarbonyl)- (9CI)
|
67482-87-5
|
C4H8N2O3S
|
|
ABZ-GLY-4-NITRO-PHE-PRO-OH
|
67482-93-3
|
C23H25N5O7
|
|
DIDS
|
67483-13-0
|
C16H8N2Na2O6S4
|
|
5-Nitro-4-[(thiazol-2-yl)azo]-1,3-benzenediol
|
67483-28-7
|
C9H6N4O4S
|
|
dihydroxy-6,7-dihydrocanrenone
|
67483-35-6
|
C22H30O5
|
|
CHEMBRDG-BB 6564340
|
67483-48-1
|
C11H12O2
|
|
3-ALLYL-4,5-DIMETHOXY-BENZALDEHYDE
|
67483-49-2
|
C12H14O3
|
|
1H-Benzimidazole-2-acetonitrile,alpha-(hydroxyimino)-1-methyl-(9CI)
|
67483-51-6
|
C10H8N4O
|
|
7,8,13,13a-Tetrahydro-5H-isoindolo[1,2-b][3]benzazepine
|
67483-53-8
|
C17H17N
|
|
2-Propenoic acid, 4'-cyano[1,1'-biphenyl]-4-yl ester
|
67483-58-3
|
C16H11NO2
|
|
7-hydroxyellipticine
|
67484-39-3
|
C17H14N2O
|
|
Hydramethylnon
|
67485-29-4
|
C25H24F6N4
|
|
2,5-DICHLOROBENZHYDRAZIDE
|
67487-35-8
|
C7H6Cl2N2O
|
|
NA-SULAS-50
|
67487-87-0
|
C28H43O3S.H4N
|
|
Racemic-(1R,2R)-Ethyl 2'-Oxospiro[Cyclopropane-1,3'-Indoline]-2-Carboxylate
|
67487-95-0
|
C13H13NO3
|
|
N-[2-(4,6-Dihydroxy-3,3,5-trimethyl-2-oxocyclohexyl)-2-hydroxy-1-(methoxymethyl)ethyl]-7-methoxy-9-methyl-4-hexadecenamide
|
67488-04-4
|
C31H57NO7
|
|
N-[2-Hydroxy-2-(4-hydroxy-3,5,5-trimethyl-6-oxo-1-cyclohexen-1-yl)-1-(methoxymethyl)ethyl]-7-methoxy-9-methyl-4-hexadecenamide
|
67488-05-5
|
C31H55NO6
|
|
2-(1-Propenyl)-2-(phenyl)tetrafluorocyclotriphosphazene
|
67488-13-5
|
C9H10F4N3P3
|
|
2,5-DIHYDROTHIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
|
67488-46-4
|
C6H8O2S
|
|
3-METHOXYCARBONYL-3-SULFOLENE
|
67488-50-0
|
C6H8O4S
|
|
Cyclopropanecarboxamide, 3-ethenyl-2,2-dimethyl-, trans- (9CI)
|
67488-72-6
|
C8H13NO
|
|
PROPANEDIOIC ACID, 2-(3-OXO-1,3-DIPHENYLPROPYL)-, 1,3-DIMETHYL ESTER
|
67488-98-6
|
C20H20O5
|
|
10-(2-Diethylaminoethyl)-10H-pyrido[3,2-b][1,4]benzothiazine
|
67489-37-6
|
C17H21N3S
|
|
Talmetacin
|
67489-39-8
|
C27H20ClNO6
|
|
1-Aziridinecarboxamide,N-(1-methylpropyl)-(9CI)
|
67489-87-6
|
C7H14N2O
|
|
16alpha-ethyl-21-hydroxy-19-norpregn-4-ene-3,20-dione 21-laurate
|
67490-00-0
|
C34H54O4
|
|
7-Oxabicyclo[4.1.0]hepta-2,4-diene-1-carboxylicacid,methylester(9CI)
|
67490-09-9
|
C8H8O3
|
|
2-Oxepincarboxylicacid,methylester(9CI)
|
67490-10-2
|
C8H8O3
|
|
Pyrimidine, 2-ethyl-4,6-dimethyl- (9CI)
|
67490-16-8
|
C8H12N2
|
|
Pyrimidine, 4,6-dimethyl-2-(1-methylethyl)- (9CI)
|
67490-17-9
|
C9H14N2
|
|
2 4 6-TRI-TERT-BUTYL PYRIMIDINE 97
|
67490-21-5
|
C16H28N2
|
|
3H-HEXAFLUOROPROPYL TRIFLUOROMETHYL ETHER
|
67490-36-2
|
C4HF9O
|
|
4,4'-DICYANO-2,2'-BIPYRIDINE
|
67491-43-4
|
C12H6N4
|
|
1H-Indole-5,6-dione,2,3-dihydro-3-hydroxy-1-(1-methylethyl)-,(R)-(9CI)
|
67491-46-7
|
C11H13NO3
|
|
N-(1,1-Dimethylethyl)-N'-benzoyl-α-(1-oxopropoxy)benzeneacetohydrazide
|
67491-63-8
|
C22H26N2O4
|
|
6-Hydroxy-3,4,8-trimethoxy-2-oxo-2H-1-benzopyran-5-carbaldehyde
|
67492-13-1
|
C13H12O7
|
|
N-Heptadecanoyl-D-erythro-sphingosine
|
67492-16-4
|
C35H69NO3
|
|
3,5-Dichlorophenylboronic acid
|
67492-50-6
|
C6H5BCl2O2
|
|
croton factor F2
|
67492-54-0
|
C38H60O8
|
|
2,4,4-trimethyl-2-phosphonoadipic acid
|
67492-83-5
|
C9H17O7P
|
|
2,2,4-trimethyl-4-phosphonoadipic acid
|
67492-84-6
|
C9H17O7P
|
|
4-decenedioic acid
|
67494-01-3
|
C10H16O4
|
|
DICHLORODIOCTADECYLSILANE
|
67494-12-6
|
C36H74Cl2Si
|
|
pisiferic acid
|
67494-15-9
|
C20H28O3
|
|
1(2H)-Naphthalenone, 3,4-dihydro-2-(1-hydroxy-1-methylethyl)-8-methyl-
|
67494-17-1
|
C14H18O2
|
|
nitriloprostaglandin I2
|
67496-60-0
|
C20H33NO4
|
|
quinuclidin-4-ylMethanaMine
|
67496-78-0
|
C8H16N2
|
|
3-(aminomethyl)adamantan-1-ol
|
67496-96-2
|
C11H19NO
|
|
Alstphyllan-19-one 4-oxide
|
67497-75-0
|
C21H24N2O3
|
|
4-Acetyl-4-demethylalstphyllan-19-one
|
67497-76-1
|
C22H24N2O3
|
|
4a(2H)-Naphthalenol,1,3,4,7,8,8a-hexahydro-8a-methyl-trans-
|
67497-82-9
|
C11H18O
|
|
2,2,2-TRIFLUOROETHANESULFONAMIDE
|
67497-95-4
|
C2H4F3NO2S
|
|
5-METHYL-2-OXO-5-PHENYL-2,5-DIHYDROFURAN-3-CARBOXYLIC ACID METHYL ESTER
|
67498-41-3
|
C13H12O4
|
|
Phenol, 2-(3-amino-2-benzofuranyl)- (9CI)
|
67498-62-8
|
C14H11NO2
|
|
6-BROMO-4-METHYL-1-PHENYLANTHRAPYRIDONE
|
67499-52-9
|
C23H14BrNO2
|
|
tolperisone hydrochloride
|
67499-62-1
|
|
|
(-)-Tolperisone hydrochloride
|
67499-63-2
|
|
|
d-Tolperisone
|
67499-64-3
|
C16H23NO
|
|
l-Tolperisone
|
67499-66-5
|
C16H23NO
|
|
1-(5-aMino-2-fluorophenyl)ethanone
|
67500-19-0
|
C8H8FNO
|
|
Cyclopropanecarboxylic acid, 2-(1-methylethenyl)-, methyl ester (9CI)
|
67500-46-3
|
C8H12O2
|
|
7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
67501-72-8
|
|
|
2'-Oxospiro[cyclopropane-1,3'-indoline]-2-carboxylic acid
|
67503-08-6
|
C11H9NO3
|
|
PHENYLAZORESORCINOL
|
67503-46-2
|
C12H10N2O2
|
|
3-acetyl-6-chloroquinolin-4(1H)-one
|
67503-73-5
|
C11H8ClNO2
|
|
Poly(acrylamide 2-methacryloxyethyltrimethyl ammonium chloride)
|
67504-24-9
|
C13H25ClN2O3
|
|
Propanoic acid, 2-methyl-, methyl ester, radical ion(1+) (9CI)
|
67505-84-4
|
C5H10O2
|
|
Cyclopropanecarboxamide, 3-ethenyl-2,2-dimethyl-, cis- (9CI)
|
67506-07-4
|
C8H13NO
|
|
(3S,3aβ)-7α-Bromo-3β-[[(E,S)-4-bromo-3,3-dimethylcyclohexylidene]methyl]octahydro-4,7aα-dimethyl-1H-inden-4α-ol
|
67506-11-0
|
C20H32Br2O
|
|
7-Bromo-3-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)hydroxymethyl]octahydro-4,7a-dimethyl-1H-inden-4-ol
|
67506-12-1
|
C20H34Br2O3
|
|
7-Bromo-3-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)hydroxymethyl]octahydro-4,7a-dimethyl-1H-indene-2,4-diol-2-acetate
|
67506-14-3
|
C22H36Br2O5
|
|
7-Bromo-3-[(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)hydroxymethyl]octahydro-4,7a-dimethyl-1H-indene-2,4-diol
|
67506-16-5
|
C20H34Br2O4
|
|
7-Bromo-α-(4-bromo-1-hydroxy-3,3-dimethylcyclohexyl)octahydro-2,4-dihydroxy-4,7a-dimethyl-1H-indene-3-methanol 3-acetate
|
67506-17-6
|
C22H36Br2O5
|
|
(3S,3aβ)-7α-Bromo-3β-[[(1S,4S)-4-bromo-1-hydroxy-3,3-dimethylcyclohexyl]methyl]octahydro-4,7aα-dimethyl-1H-inden-4α-ol
|
67506-19-8
|
C20H34Br2O2
|
|
[1,2,5]Oxadiazolo[3,4-b]quinoxaline (9CI)
|
67506-48-3
|
C8H4N4O
|
|
BIS(PENTAMETHYLCYCLOPENTADIENYL)MANGANESE
|
67506-86-9
|
C20H30Mn10*
|
|
dichlorouranium, 1,2,3,4,5-pentamethylcyclopentane
|
67506-89-2
|
C20H30Cl2U
|
|
carbanide, 1,2,3,4,5-pentamethylcyclopentane, thorium
|
67506-90-5
|
C22H34Th
|
|
prostaglandin F2alpha N-dimethylamide
|
67508-08-1
|
C22H39NO4
|
|
N-dimethylaminoprostaglandin F2alpha
|
67508-09-2
|
C22H41NO3
|
|
(1R)-1,2,3,4,6,11-Hexahydro-4α-[[3-(methylamino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-6,11-dioxo-2-ethyl-2α,5,7-trihydroxy-1β-naphthacenecarboxylic acid methyl ester
|
67508-85-4
|
C28H31NO10
|
|
N,N-dimethyldaunorubicin
|
67508-87-6
|
C29H33NO10
|
|
1-Naphthacenecarboxylic acid, 1,2,3,4,6,11-hexahydro-6,11-dioxo-2-ethy l-4-((2,3,6-trideoxy-3-amino-alpha-L-lyxo-hexopyranosyl)oxy)-2,5,7-tri hydroxy-, methyl ester, (1R-(1-alpha,2-beta,4-beta))-
|
67508-88-7
|
C28H31NO10
|
|
5-mercurideoxyuridine triphosphate
|
67508-92-3
|
|
|
N-AcetylAngiotensinI(Human)
|
67509-13-1
|
C64H91N17O15
|
|
H-SER-GLU-GLY-OH
|
67509-32-4
|
C10H17N3O7
|
|
3-aminonocardicinic acid
|
67509-41-5
|
C11H12N2O4
|
|
1,5-Naphthyridine-2-carboxylic acid, hydrazide
|
67510-41-2
|
C9H8N4O
|
|
1,5-Naphthyridine-2-carboxamide, 5-oxide
|
67510-42-3
|
C9H7N3O2
|
|
4-(Trifluoroacetyl)-4-demethylalstphyllan-19-one
|
67510-47-8
|
C22H21F3N2O3
|